Related Experiment Video

Updated: Aug 17, 2026

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Prostate cancer cell survival pathways activated by bone metastasis microenvironment

R Tenta1, E Sotiriou, N Pitulis

  • 1Department of Experimental Physiology, Medical School, University of Athens, Goudi, Athens, Greece.

Journal of Musculoskeletal & Neuronal Interactions
|June 14, 2005
PubMed

Insights

Prostate cancer resistance in bone metastases is a challenge. Targeting bone microenvironment pathways offers a new strategy to improve anti-cancer therapy effectiveness and patient survival.

Area of Science:

  • Oncology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Bone metastasis is a significant challenge in hormone-refractory prostate cancer, often leading to therapeutic resistance.
  • Prostate cancer cells in the bone microenvironment activate specific signaling pathways that promote survival and hinder treatment efficacy.
  • Understanding these pathways is crucial for developing more effective treatments for advanced prostate cancer.

Purpose of the Study:

  • To identify and describe the key signal transduction pathways activated in prostate cancer cells within the bone metastasis microenvironment.
  • To elucidate how these pathways contribute to resistance against anti-cancer therapies by inhibiting apoptosis.
  • To establish a framework for developing novel bone-targeted therapies for advanced prostate cancer.

Main Methods:

  • Analysis of signal transduction pathways activated in prostate cancer cells within bone metastasis models.
  • Investigation of the role of these pathways in mediating resistance to anti-cancer therapies.
  • Evaluation of the potential of targeting the bone metastasis microenvironment for therapeutic benefit.

Main Results:

  • Specific intracellular signal transduction pathways are activated in prostate cancer cells residing in the bone microenvironment.
  • These activated pathways inhibit therapy-induced apoptosis, promoting cancer cell survival locally.
  • The bone metastasis microenvironment actively protects cancer cells from treatment.

Conclusions:

  • Targeting the bone metastasis microenvironment represents a novel therapeutic paradigm for advanced prostate cancer.
  • Therapeutic strategies can be designed to neutralize the protective effects of the microenvironment, in addition to directly inducing cancer cell death.
  • This approach holds promise for overcoming resistance and improving clinical outcomes in hormone-refractory prostate cancer.

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines06:00

Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines

Published on: September 13, 2017

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...